In an era of widespread genetic sequencing, the ability to edit and alter an organism’s DNA is a powerful way to explore the information within and how it guides biological function.
A paper from the University of Wisconsin-Madison in the August issue of the journal GENETICS takes genome editing to a new level in fruit flies, demonstrating a remarkable level of fine control and, importantly, the transmission of those engineered genetic changes across generations.
Both features are key for driving the utility and spread of an approach that promises to give researchers new insights into the basic workings of biological systems, including embryonic development, nervous system function, and the understanding of human disease.
“Genome engineering allows you to change gene function in a very targeted way, so you can probe function at a level of detail” that wasn’t previously possible, says Melissa Harrison, an assistant professor of biomolecular chemistry in the UW-Madison School of Medicine and Public Health and one of the three senior authors of the new study.
Disrupting individual genes has long been used as a way to study their roles in biological function and disease. The new approach, based on molecules that drive a type of bacterial immune response, provides a technical advance that allows scientists to readily engineer genetic sequences in very detailed ways, including adding or removing short bits of DNA in chosen locations, introducing specific mutations, adding trackable tags, or changing the sequences that regulate when or where a gene is active.
The approach used in the new study, called the CRISPR RNA/Cas9 system, has developed unusually fast. First reported just one year ago by scientists at the Howard Hughes Medical Institute and University of California, Berkeley, it has already been applied to most traditional biological model systems, including yeast, zebrafish, mice, the nematode C. elegans, and human cells. The Wisconsin paper was the first to describe it in fruit flies and to show that the resulting genetic changes could be passed from one generation to the next.
“There was a need in the community to have a technique that you could use to generate targeted mutations,” says Jill Wildonger, a UW-Madison assistant professor of biochemistry and another senior author of the paper. “The need was there and this was the technical advance that everyone had been waiting for.”
“The reason this has progressed so quickly is that many researchers — us included — were working on other, more complicated, approaches to do exactly the same thing when this came out,” adds genetics assistant professor Kate O’Connor-Giles, the third senior author. “This is invaluable for anyone wanting to study gene function in any organism and it is also likely to be transferable to the clinical realm and gene therapy.”
The CRISPR RNA/Cas9 system directs a DNA-clipping enzyme called Cas9 to snip the DNA at a targeted sequence. This cut then stimulates the cell’s existing DNA repair machinery to fill in the break while integrating the desired genetic tweaks. The process can be tailored to edit down to the level of a single base pair — the rough equivalent of changing a single letter in a document with a word processor.
The broad applicability of the system is aided by a relatively simple design that can be customized through creation of a short RNA sequence to target a specific sequence in the genome to generate the desired changes. Previous genome editing methods have relied on making custom proteins, which is costly and slow.
“This is so readily transferable that it’s highly likely to enable gene knockout and other genome modifications in any organism,” including those that have not previously been used for laboratory work, says O’Connor-Giles. “It’s going to turn non-model organisms into genetic model organisms.”
That ease may also pay off in the clinic. “It can be very difficult and time-consuming to generate models to study all the gene variants associated with human diseases,” says Wildonger. “With this genome editing approach, if we work in collaboration with a clinician to find [clinically relevant] mutations, we can rapidly translate these into a fruit fly model to see what’s happening at the cellular and molecular level.”
The Latest on: Genome editing
- Biology: New gene editing calls for ways to regulate iton July 7, 2019 at 1:56 am
Last month, the U.S. National Academies of Sciences and of Medicine and the U.K. Royal Society launched an International Commission to propose guidelines for possible, clinical applications of a new ... […]
- Attitudes of clinical geneticists and certified genetic counselors toon July 5, 2019 at 1:27 pm
Genome editing of the human embryo using CRISPR/Cas9 has the potential to prevent hereditary diseases from being transmitted to the next generation. However, attitudes to this technology have not been ... […]
- Veritas is slashing costs to beat back rivals like 23andMeon July 5, 2019 at 8:31 am
including the Human Genome Project and the development of CRISPR— a genome editing technique that allows scientists to cut and paste lines of DNA like text in a Word document. Church holds identical ... […]
- Editas (EDIT) Focuses on Developing Eye Candidate EDIT-101on July 5, 2019 at 6:40 am
The company has a strategic alliance and option agreement with Allergan under which, the latter reserves rights to in-license up to five of Editas’ genome editing ocular programs. Last July ... […]
- Genome editing to help cope with food demandon July 4, 2019 at 12:33 am
The new technique, used to rewrite the genetic code, is a better alternative to enhance the quality and quantity of the crops, writes Deepa Khare World population is increasing exponentially and ... […]
- An anionic human protein mediates cationic liposome delivery of genome editing proteins into mammalian cellson July 2, 2019 at 2:28 am
Delivery into mammalian cells remains a significant challenge for many applications of proteins as research tools and therapeutics. We recently reported that the fusion of cargo proteins to a ... […]
- Global Genome Editing Market Worth Reach USD 9.66 Billion By 2025on June 29, 2019 at 12:47 am
(MENAFN - Zion Market Research) Zion Market Research has published a new report titled 'Genome Editing Market by Technology (CRISPR, TALEN, ZFN, Antisense, and Others), by Application (Cell Line ... […]
- Gene Editing Techniques: ZFNs, TALENs or CRISPR?on June 28, 2019 at 2:16 am
Engineered nucleases, enzymes containing a nucleotide-specific DNA-binding domain fused to a non-specific DNA cleavage domain, are an essential component of genome editing. The product of nuclease ... […]
- Don’t look for FDA to “pork out” as the nation’s top regulator of livestock genome editingon June 27, 2019 at 9:00 pm
The pork industry earlier this week said it wants to get the Food and Drug Administration (FDA) out of regulating livestock genome editing. But unless pigs fly, that possibility seems pretty remote. ... […]
- A catalog of CasX genome editing sites in common model organismson June 27, 2019 at 6:39 am
Genome editing is a powerful molecular tool that allows for permanent genomic alteration. Currently the most widely used system is the Streptococcus pyogenes clustered regularly interspaced short ... […]
via Google News and Bing News